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Killer cell lectin-like receptor G1 (KLRG1) receptor is considered to be a marker of term-
inally differentiated NK and T cells and is strongly induced by viral and other infections.
KLRG1 is a C-type lectin-like inhibitory receptor, which interacts with members of the
cadherin family of molecules leading to the inhibition of T- and NK-cell function. A study
in this issue of the European Journal of Immunology addresses the role of KLRG1 in the
maturation and differentiation of NK and T cells in vivo. Using KLRG1-deficient mice
generated by homologous recombination, the study reveals that KLRG1 is dispensable for
NK- and CD81 T-cell differentiation and function in vivo. This interesting finding is
discussed in this Commentary in light of the plasticity and robustness of immune response
mechanisms.
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Killer cell lectin-like receptor G1 (KLRG1) is an inhibitory receptor
of the C-type lectin-like family, which contains an ITIM in its
cytoplasmic domain [1, 2]. It is expressed on certain subsets of NK
and T cells that have an effector or effector-memory phenotype [3,
4]. KLRG1 is generally used as a marker of terminally differ-
entiated NK and T cells and is strongly induced by viral and other
infections [3]. KLRG1 expression by NK cells after viral infection
inversely correlates with NK cells’ ability to produce
IFN-g [5]. Experimental evidence indicates that the interaction of
KLRG1 with its cognate ligand, E-cadherin [6] can result in the
inhibition of T- and NK-cell function [7, 8]. It has been proposed
that KLRG1 raises the activation threshold of NK and T cells,
thereby attenuating effector responses and reducing the risk of
autoreactivity [9, 10]. However, these KLRG1–E-cadherin interac-
tions appear to be very weak and may be functionally significant
only under conditions where multimeric receptor/ligand
complexes are formed [8]. It has been suggested that NK cells
bearing KLRG1 can monitor the expression of several cadherins on
target cells, resulting in MHC-independent missing self-recognition
[11]. The functional role for KLRG1 in primary human CD81 T
cells was recently demonstrated by blocking KLRG1 signaling
using antibodies against E-cadherin. This resulted in a significant
enhancement of Akt phosphorylation and TCR-induced prolifera-
tive activity of senescent T cells [12].
Although the idea of KLRG1 being a marker of terminally
differentiated lymphocytes makes sense, the majority of conclu-
sions reached so far stem from in vitro data, and major insights
remain to come from in vivo studies. To address the role of KLRG1
in the maturation and differentiation of NK and T cells in vivo,
Gru¨ndemann et al. [13] in this issue of the European Journal of
Immunology present very interesting data on the generation and
characterization of KLRG1-deficient mice obtained by homologous
recombination. By elegantly designing a well-controlled set of
experiments in several relevant infection models, the authors show
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that KLRG1 deficiency affects neither the differentiation nor the
function of NK or CD81 T cells. In addition, KLRG1/ mice
generate a normal antiviral CD81 T-cell response during both the
acute and memory phase of infection. Thus, despite the fact that
KLRG1 is abundantly expressed on anti-viral effector CD81 T cells,
KLRG1 deficiency does not affect the induction of antigen-specific
CD81 T cells after viral infection. Adoptively transferred T cells
from KLRG1/ and WT mice proliferate to the same extent in
recipient mice after LCMV infection, and give rise to similar
numbers of memory T cells. The expression of typical markers on
effector and memory T cells and their capacity to secrete IFN-g and
IL-2 after antigen stimulation was also unaffected. In agreement
with previous results, the authors also show that KLRG1 ligand
expressed on target cells can inhibit the reactivity of NK cells that
are derived from transgenic mice overexpressing KLRG1, but not
NK cells derived from either KLRG1/ or WT mice. The expla-
nation for this finding is that the KLRG1–ligand interaction is very
weak, and hence a strong activating signal can overcome the
inhibition induced by KLRG1. Surprisingly, NK cells from
KLRG1/ mice are more strongly activated after co-culture with
cells expressing E-cadherin compared with control cells that do not
express this ligand, perhaps suggesting the involvement of an
activating receptor.
What do gene KO mice lacking this seemingly important
receptor but showing no expected phenotype teach us? Is it really
possible that KLRG1 does not play an important role in NK-cell
and T-cell biology? When drawing conclusions from such find-
ings, one has to bear in mind that the immune system, like any
other physiological system, is able to compensate even for the
lack of physiologically important functions. There are many
examples of KO mice in which the targeted function is not
affected, although one might have expected dramatic changes
based on the known function of the gene (for review see [14]).
The immune system is in fact one of the best examples of the
importance of functional redundancy regardless of whether it is
compensation by other homologous genes, or functional
compensation at other levels of biological organization. In a
biological context, functional redundancy is extremely important
when it comes to dealing with infections, as it is essential that the
elimination of invading microbes does not rely on a single
mechanism. This is why it does not come as a surprise that the
deletion of only one receptor or even a cell type involved in
immune control will not necessarily result in an obvious pheno-
type. As Gru¨ndemann et al. rightly emphasize, the function of NK
and CD81 T cells is regulated via a number of activating and
inhibitory receptors and the lack of only one inhibitory receptor
will not necessarily cause functional alterations.
As an example of the robustness of immune control, it is
important to point out the recently published data on NKG2D-KO
mice [15, 16]. NKG2D is a dominant activating receptor on NK
cells and a co-stimulatory receptor on CD81 T cells. It recognizes
several different ligands induced by cellular stress or transforma-
tion. It has been shown that NKG2D plays an important role in the
control of MCMV infection in vivo; its importance is additionally
illustrated by the fact that both human and mouse CMV encode
both proteins and miRNA, which downregulate the expression of
NKG2D0s ligands [17]. Thus, it makes perfect sense to assume that
NKG2D-KO mice might have at least some difficulties in the early
control of MCMV infection; however, it turns out that KO mice
control MCMV infection equally well, or even better in some
tissues, than control mice. Although the mechanism underlying
this finding has not yet been characterized, the results highlight the
plasticity of immune control mechanisms. Not all functions of
NKG2D, however, can be compensated for. As reported by Guerra
et al. [16], NKG2D is critical for immunosurveillance of epithelial
and lymphoid malignancies. In another study, the deletion of
another NK-cell-activating receptor, NKp46 (NCR1), also did not
result in any changes in the maturation and differentiation of NK
cells [18]; however, as NKp46 binds to influenza hemaglutinin, the
KO mouse is very sensitive to the influenza virus. An interesting
phenotype of this mutant mouse strain was recently described,
suggesting that NKp46 may be involved in progression of type 1
diabetes by interfering with unexpected NK-cell-mediated recog-
nition of pancreatic beta cells [19], thus indicating that situations
may be more complicated than first assessed.
To further emphasize the plasticity and robustness of the
immune response, I will give a few additional examples. In early
studies, before the era of KO mice, the depletion of T-cell subsets
by specific monoclonal antibodies in thymectomized mice was
used to create mice lacking a particular type of cells. Such animals
were useful tools for elucidating the role of individual subsets in
the control of virus infection or other type of immune response.
Using the model of MCMV infection, some light was shed on the
role of T-cell subsets in virus control [20]. Until then, the results
obtained by adoptive transfer of primed T cells into immunodefi-
cient syngeneic recipients clearly demonstrated that CD81 T cells
were essential for virus control, whereas adoptively transferred
CD41 T cells were neither able to reduce the virus titer, nor were
they required for antiviral activity of CD81 cells [21]. Therefore, it
could be expected that the depletion of CD81 cells would
compromise the ability of these mice to cope with CMV infection,
whereas the depletion of CD41 cells would have a less significant
impact on virus control. The results, however, turned out to be
quite the opposite of what was expected, as mice lacking CD81
T cells cleared the virus with the same kinetics as normal, fully
immunocompetent animals [20, 22]. It has also been shown that
in the absence of CD81 cells, virus control is compensated for by a
CD41-cell-dependent mechanism. Therefore, although CD81 cells
are the dominant effector cells in the control of MCMV infection,
they are not indispensable, at least according to this particular
experimental setting. Moreover, although CD41 cells derived from
immune mice were unable to mediate a protective function after
adoptive transfer, depletion experiments in thymectomized mice
revealed an, until then, unknown function of this subset that could
not be compensated for by CD81 or any other cells [22]. This
function was deduced, as a persistent infection in acinar glandular
epithelial cells of salivary glands occurred in CD4-depleted mice
and because salivary glands are the major source of CMV for
horizontal spread. Thus, it could be concluded that CD41 cells are
essential for this function.
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There are many other examples in physiology and cell biology,
which show successful compensation for a missing gene and its
function or even for entire cell subsets. The effect of some genes
might be evident only upon inactivation of another gene. Genetic
robustness may also depend on the mouse strain used, as specific
alleles of genes present in certain inbred mouse strains have been
shown to either partially or completely mask the effects of genetic
mutations. Thus, the KLRG1 inactivation in another mouse strain
might eventually uncover other, so far unknown, functions of this
receptor.
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